Mandate

Vinge advises Lantmännen in connection with formation of poultry group together with CapVest

April 05, 2013

Vinge has advised Lantmännen co-operative association in connection with the sale of Kronfågel to a newly-formed company which will become the Nordic region’s leading poultry producer and in which Lantmännen will remain a stakeholder with 48% of the voting capital.

The new group, which will be jointly owned together with the British private equity company, CapVest, will consist of Kronfågel, Swehatch and Skånefågel in Sweden, Danpo in Denmark and Cardinal Foods in Norway and will have an annual turnover of approximately SEK 5.4 billion. The transaction is subject to approval by the relevant competition authorities in Denmark, Norway and Sweden.

Vinge’s team consisted of responsible partner Christina Kokko together with associates Paul Dali, Johan Mattsson, Mia Örnfeldt, Gustav Jönsson and Filip Öhrner as well as Fredrik Gustafsson (employment and pensions), Karin Isacson (employment and pensions), Johan Cederblad (environmental and permit issues). Partner Mikael Ståhl and associates Louise Brorsson Salomon, Sofia Graflund and Albert Wållgren advised on external financing issues relating to the new group.

Related

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024

Vinge advises Triton in connection with the divestment of Norstat to Nalka Invest

Vinge advises Triton Smaller Mid-Cap Fund I (“Triton”) in connection with the divestment of Norstat, a leading data collector for market research, to Nalka Invest.
April 12, 2024